Literature DB >> 27265430

Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

Lior Cohen1, Shay Tzur2, Nitza Goldenberg-Cohen3, Concetta Bormans4, Doron M Behar4, Eyal Reinstein5.   

Abstract

Inherited optic neuropathies are a heterogeneous group of disorders characterized by mild to severe visual loss, colour vision deficit, central or paracentral visual field defects and optic disc pallor. Optic atrophies can be classified into isolated or non-syndromic and syndromic forms. While multiple modes of inheritance have been reported, autosomal dominant optic atrophy and mitochondrial inherited Leber's hereditary optic neuropathy are the most common forms. Optic atrophy type 1, caused by mutations in the OPA1 gene is believed to be the most common hereditary optic neuropathy, and most patients inherit a mutation from an affected parent. In this study we used whole-exome sequencing to investigate the genetic aetiology in a patient affected with isolated optic atrophy. Since the proband was the only affected individual in his extended family, and was a product of consanguineous marriage, homozygosity mapping followed by whole-exome sequencing were pursued. Exome results identified a novel de novo OPA1 mutation in the proband. We conclude, that though de novo OPA1 mutations are uncommon, testing of common optic atrophy-associated genes such as mitochondrial mutations and OPA1 gene sequencing should be performed first in single individuals presenting with optic neuropathy, even when dominant inheritance is not apparent.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27265430      PMCID: PMC6865152          DOI: 10.1017/S0016672316000070

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  16 in total

1.  A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.

Authors:  Pablo Cingolani; Adrian Platts; Le Lily Wang; Melissa Coon; Tung Nguyen; Luan Wang; Susan J Land; Xiangyi Lu; Douglas M Ruden
Journal:  Fly (Austin)       Date:  2012 Apr-Jun       Impact factor: 2.160

2.  OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.

Authors:  U E Pesch; B Leo-Kottler; S Mayer; B Jurklies; U Kellner; E Apfelstedt-Sylla; E Zrenner; C Alexander; B Wissinger
Journal:  Hum Mol Genet       Date:  2001-06-15       Impact factor: 6.150

3.  Mutations in TAX1BP3 cause dilated cardiomyopathy with septo-optic dysplasia.

Authors:  Eyal Reinstein; Katia Orvin; Einav Tayeb-Fligelman; Hadas Stiebel-Kalish; Shay Tzur; Allen L Pimienta; Lily Bazak; Tuvia Bengal; Lior Cohen; Dan D Gaton; Concetta Bormans; Meytal Landau; Ran Kornowski; Mordechai Shohat; Doron M Behar
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

Review 4.  Genetics of Primary Inherited Disorders of the Optic Nerve: Clinical Applications.

Authors:  Keri F Allen; Eric D Gaier; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

5.  Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.

Authors:  Amy C Cohn; Carmel Toomes; Catherine Potter; Katherine V Towns; Alex W Hewitt; Chris F Inglehearn; Jamie E Craig; David A Mackey
Journal:  Am J Ophthalmol       Date:  2007-02-15       Impact factor: 5.258

Review 6.  Costeff optic atrophy syndrome: new clinical case and novel molecular findings.

Authors:  G Ho; J H Walter; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2008-11-07       Impact factor: 4.982

7.  Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.

Authors:  Marc Ferré; Dominique Bonneau; Dan Milea; Arnaud Chevrollier; Christophe Verny; Hélène Dollfus; Carmen Ayuso; Sabine Defoort; Catherine Vignal; Xavier Zanlonghi; Jean-Francois Charlin; Josseline Kaplan; Sylvie Odent; Christian P Hamel; Vincent Procaccio; Pascal Reynier; Patrizia Amati-Bonneau
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

8.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Ailbhe Burke; Peter W Sellar; Michael P Clarke; Lawrence Gnanaraj; Desiree Ah-Kine; Gavin Hudson; Birgit Czermin; Robert W Taylor; Rita Horvath; Patrick F Chinnery
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

Review 9.  Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics.

Authors:  Marcel V Alavi; Nico Fuhrmann
Journal:  Mol Neurodegener       Date:  2013-09-25       Impact factor: 14.195

Review 10.  Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.

Authors:  Gerald Pfeffer; Ailbhe Burke; Patrick Yu-Wai-Man; D Alastair S Compston; Patrick F Chinnery
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

View more
  2 in total

1.  Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay.

Authors:  Aneta Ścieżyńska; Ewelina Ruszkowska; Kamil Szulborski; Katarzyna Rydz; Joanna Wierzbowska; Joanna Kosińska; Marek Rękas; Rafał Płoski; Jacek Paweł Szaflik; Monika Ołdak
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

2.  First Description of Inheritance of a Postzygotic OPA1 Mosaic Variant.

Authors:  Svenja Alter; Navid Farassat; Sebastian Küchlin; Wolf A Lagrèze; Judith Fischer
Journal:  Genes (Basel)       Date:  2022-03-08       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.